Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „elapse“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · In patients with relapsed or refractory HL or sALCL who were retreated with ADCETRIS (SGN35-006), the majority
Eintrag öffnenAdcetris · 4.8 · Safety was evaluated in a phase 1/2 study in paediatric patients aged 7-17 years of age (n = 36) with relapsed
Eintrag öffnenAdcetris · 4.8 · The safety data in patients with relapsed or refractory HL who had not received an autologous stem cell transp
Eintrag öffnenBesponsa · 4.8 · BESPONSA has been evaluated in 53 paediatric patients ≥ 1 and < 18 years of age with relapsed or refractory CD
Eintrag öffnenBesponsa · 4.8 · In Cohort 3 of the Phase 2 ITCC-059 trial thirty-five VHR first relapsed BCP-ALL patients had at least 1 adver
Eintrag öffnenBesponsa · 4.8 · In clinical studies of inotuzumab ozogamicin in adult patients with relapsed or refractory ALL, 7/236 (3%) pat
Eintrag öffnenBesponsa · 4.8 · In clinical study ITCC-059 of inotuzumab ozogamicin in paediatric patients with relapsed or refractory ALL (N=
Eintrag öffnenBesponsa · 4.8 · Table 5 shows the adverse reactions reported in adult patients with relapsed or refractory ALL who received BE
Eintrag öffnenBesponsa · 4.8 · Table 5. Adverse reactions reported in adult patients with relapsed or refractory B-cell precursor ALL who rec
Eintrag öffnenBesponsa · 4.8 · Table 6 shows the adverse reactions reported in paediatric patients with relapsed or refractory ALL who receiv
Eintrag öffnenBesponsa · 4.8 · Table 6. Adverse reactions reported in paediatric patients with relapsed or refractory B-cell precursor ALL wh
Eintrag öffnenBlincyto · 4.8 · BLINCYTO has also been evaluated in paediatric patients with high-risk first relapsed B-cell precursor ALL in
Eintrag öffnenBlincyto · 4.8 · Neurologic events were reported for 62.2% of adult patients with Philadelphia chromosome-positive relapsed or
Eintrag öffnenBlincyto · 4.8 · Study MT103-205 was a dose escalation/evaluation study in paediatric patients with relapsed or refractory B-ce
Eintrag öffnenBortezomib Accord · 4.8 · 21 Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was admin
Eintrag öffnenBortezomib Accord · 4.8 · 54 Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was admin
Eintrag öffnenBusulfan Fresenius Kabi · 4.8 · The treatment-related mortality/non-relapse mortality (TRM/NRM) reported until day+100 post- transplant has al
Eintrag öffnenColumvi · 4.8 · 15 Adverse reactions occurring in relapsed or refractory DLBCL patients treated with Columvi in combination wi
Eintrag öffnenColumvi · 4.8 · 17 Table 7. Adverse reactions reported in patients with relapsed or refractory DLBCL treated with Columvi in c
Eintrag öffnenColumvi · 4.8 · Adverse reactions occurring in relapsed or refractory DLBCL patients treated with Columvi monotherapy (n=145)
Eintrag öffnen